This report is being submitted retrospectively as part of an internal review.Bleeding at insertion site (while inserting or removing the sensor) is a known and anticipated potential adverse effect.This does not require any further investigation.User immediately went to the hospital where stitches were put to stop bleeding.The insertion site healed well after that.Patient/user is currently using eversense xl cgm system.There is no remedial action/corrective action/preventive action/field safety corrective action required.
|